학술논문
Epcoritamab induces potent anti-tumor activity against malignant B-cells from patients with DLBCL, FL and MCL, irrespective of prior CD20 monoclonal antibody treatment
Document Type
Article
Author
Source
In: Blood Cancer Journal . (Blood Cancer Journal, February 2021, 11(2))
Subject
Language
English
ISSN
20445385